thumbnail
Supplement RegulationsWith Chevron deference gone, will NAC rulemaking cause problems for FDA?With Chevron deference gone, will NAC rulemaking cause problems for FDA?
FDA is looking into exercising notice-and-comment rulemaking authority in DSHEA for the first time in the law’s 30-year history. So what are the larger implications of this endeavor for the supplement sector?
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.